Intersect ENT, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017
Operating activities:
Net loss
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization
Amortization of right-of-use assets
Non-cash lease expense
Stock-based compensation expense
Amortization of net investment premium
Amortization of net investment premium (discount)
Amortization of debt transaction costs and accretion of debt discount
Impairment of property, equipment, and intangible assets
Impairment on assets held for sale
Interest expense on deferred acquisition related costs
Loss (gain) on foreign currency forward contracts
Foreign currency remeasurement loss (gain)
Change in fair value of embedded derivatives
Income tax (benefit)

Changes in operating assets and liabilities, net of held for sale:
Accounts receivable, net
Inventories, net
Prepaid expenses and other assets
Accounts payable
Accrued compensation
Other liabilities
Net cash used in operating activities
Investing activities:
Purchases of short-term investments
Maturities of short-term investments
Proceeds from sale of short-term investments
Purchases of property and equipment
Cash paid for acquisition, net
Net cash provided by (used in) investing activities
Financing activities:
Proceeds from debt financing, net of issuance costs
Payment of deferred acquisition related consideration
Proceeds from issuance of common stock and exercise of stock options
Net cash provided by financing activities
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
Net increase (decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash:
End of the period
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Beginning of the period
Reclassification to assets held for sale during the period
End of the period, excluding amounts classified as assets held for sale
Supplementary cash flow information of non-cash investing and financing activities:
Right-of-use asset obtained in exchange for lease obligations
Right-of-use asset remeasurement subsequent to lease extension
Right-of-use asset remeasurement related to lease extension
Lessor funded building improvements
Deferred purchase consideration for a business combination
Property and equipment included in accounts payable
Supplementary cash flow information:
Cash paid for interest on long-term debt

Comments